Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Stress and Response to Uvb Irradiation Using the Suction
Protein/Protein Interactions on Hsv DNA Polymerase
Mechanism of Action of Cannabis
Vasoactive Lipoxygenase Products in Glomerular Injury
Recently added grants:
Generalizable prediction of medication adherence in heart failure
Identifying mechanisms and reversibility of eosinophil-induced airway hyperinnervation in asthma
Mesenchymal modulation of epithelial metaplasia in lung fibrosis
Developmental origins and early detection of ADHD and dysregulatory psychopathology
Development of Precision Analyses to Reveal Hit&Run Effects
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant